Project Grant R21ES038413
- The National Institute of Environmental Health Sciences awarded The University of Texas Southwestern Medical Center $649,193 on April 1, 2026, under the Environmental Health program (CFDA 93.113, Project Grant R01ES038329) to investigate molecular mechanisms of epitranscriptomic dysregulation induced by toxic metals. The research examines how naturally occurring heavy metals—arsenic, cadmium, chromium, and nickel—impact post-transcriptional gene regulation through RNA modifications and...
- The National Institute of Environmental Health Sciences awarded $124,107 to the University of Texas at Austin on September 1, 2026, under the Environmental Health program (CFDA 93.113) to conduct research on extracellular vesicles as mediators of epigenetic changes induced by environmental endocrine-disrupting chemicals in male reproductive health. The research investigates how exposure to endocrine-disrupting chemicals modifies epididymosome cargo—specifically small non-coding RNA...
- The National Institute of Environmental Health Sciences, a component of the Department of Health and Human Services National Institutes of Health, awarded the University of Texas at Austin $415,906 on June 1, 2026, under the Environmental Health program (CFDA 93.113) to investigate how air pollution induces shifts in the RNA modification landscape and how pseudouridine-incorporating enzymes relocalize in response to airborne toxins. The research examines whether exposure to ambient air pollution...
- The National Institute of Environmental Health Sciences awarded New York University School of Medicine $3.234 million on June 20, 2026, under the Environmental Health program (CFDA 93.113, Assistance Listing R01ES037626) to investigate the molecular mechanisms by which nickel exposure disrupts transcriptional regulation and causes lung disease. The research examines how nickel compounds, prevalent in industrial processes and consumer products including stainless steel and batteries, drive...
- The National Institute of Environmental Health Sciences awarded Florida International University $489,258 on April 24, 2026, under the Environmental Health program (CFDA 93.113) to investigate the crosstalk of epitranscriptomic RNA modifications and DNA damage repair mechanisms, with performance through March 31, 2031, at the Miami, Florida campus. The research examines how environmentally induced RNA damage, the epitranscriptomic mark N6-methyladenosine (M6A), and DNA base damage interact on...
- The National Institute of Environmental Health Sciences awarded The University of Chicago $735,782 on July 10, 2026, under the Environmental Health program (CFDA 93.113) to conduct research on chromatin regulation through RNA demethylation in environmental stress response. The project investigates N6-methyladenosine (M6A) modifications on messenger RNA and chromatin-associated RNA, focusing on how FTO and ALKBH1 demethylases regulate these modifications in response to environmental stressors...
- The National Institute of Environmental Health Sciences awarded New York University $2,518,755 on September 16, 2025, under the Environmental Health program (CFDA 93.113) to investigate the role of NEDD9 and chromium(VI) in carcinogenesis. The research examines how chronic chromium(VI) exposure generates reactive oxygen species and impairs autophagy, leading to upregulation of NEDD9 and P62 proteins that promote malignant cell transformation and tumorigenesis in non-small cell lung carcinomas....
- The National Institute of Environmental Health Sciences, part of the National Institutes of Health under the Department of Health and Human Services, awarded the University of Pittsburgh $127,384 on September 11, 2025, under the Environmental Health program (CFDA 93.113) for research into the dynamics of oxidative DNA demethylation. The award supports a mentored K99/R00 career development grant. During the mentored K99 phase, the candidate will receive training in multiple techniques including...
- The National Institute of Environmental Health Sciences awarded $429,000 to the Regents of the University of Michigan on September 2, 2026, to investigate early life toxicant and psychosocial co-exposures and their associations with adolescent and emerging adult mental health, under the Environmental Health program (CFDA 93.113), with performance through September 1, 2028. The research uses the ELEMENT cohort, a longitudinal scientific resource with over 30 years of follow-up and extensive...
- The National Institute of General Medical Sciences awarded the University of Texas at Austin $429,650 on April 6, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the interplay between cellular metabolism, chromatin regulation, and transcriptional control in ethylene signaling and stress responses in Arabidopsis. The research explores how chromatin-modifying enzymes utilize metabolic cofactors to influence histone modifications, nucleosome structure,...
The National Institute of Environmental Health Sciences awarded $240,000 to the University of Texas at Austin on September 1, 2026, under the Environmental Health program (CFDA 93.113) to investigate how environmental metals including nickel and cadmium alter DNA and chromatin structures and gene expression. The research will determine the effects of metal exposure and cytosine methylation on non-B DNA formation, chromatin assembly, and gene expression in mammalian cells. The project hypothesizes that exposure to environmental metals stimulates epigenetic modifications that induce alternative DNA structures—such as Z-DNA and H-DNA—which impede transcription progression by stalling RNA polymerases, thereby dysregulating gene expression. Specific aims include determining how cytosine methylation affects non-B DNA structure formation and chromatin conformation, and characterizing the mechanisms by which metal-induced epigenetic changes modulate transcription through alterations in DNA and chromatin conformations. The work is intended to identify novel approaches to attenuate metal-induced dysregulation of gene expression. The award funds research conducted at the University of Texas at Austin in Austin, Texas, with a performance period from September 1, 2026, through August 31, 2028. The assistance type is a Project Grant, classified as R21 funding within the National Institutes of Health portfolio. The University of Texas System is the parent organization of the University of Texas at Austin.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $240.0k | 9/1/26 |